Literature DB >> 12430856

The use of high dose immunoablative therapy with hematopoietic stem cell support therapy in the treatment of severe autoimmune diseases.

Alan Tyndall, Alois Gratwohl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12430856     DOI： 10.1007/bf03165249

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  9 in total

Review 1.  Autoimmune disease: why and where it occurs.

Authors:  P Marrack; J Kappler; B L Kotzin
Journal:  Nat Med       Date:  2001-08       Impact factor: 53.440

Review 2.  Autoimmune diseases.

Authors:  A Davidson; B Diamond
Journal:  N Engl J Med       Date:  2001-08-02       Impact factor: 91.245

3.  Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease.

Authors:  M Binks; J R Passweg; D Furst; P McSweeney; K Sullivan; C Besenthal; J Finke; H H Peter; J van Laar; F C Breedveld; W E Fibbe; D Farge; E Gluckman; F Locatelli; A Martini; F van den Hoogen; L van de Putte; A V Schattenberg; R Arnold; P A Bacon; P Emery; I Espigado; B Hertenstein; F Hiepe; A Kashyap; I Kötter; A Marmont; A Martinez; M J Pascual; A Gratwohl; H G Prentice; C Black; A Tyndall
Journal:  Ann Rheum Dis       Date:  2001-06       Impact factor: 19.103

Review 4.  Regulatory T cells in autoimmmunity*.

Authors:  E M Shevach
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

5.  Haemopoietic stem and progenitor cells in the treatment of severe autoimmune diseases.

Authors:  A Tyndall; A Gratwohl
Journal:  Ann Rheum Dis       Date:  1996-03       Impact factor: 19.103

6.  Autologous haemopoietic stem cell transplantation in a patient with severe pulmonary hypertension complicating connective tissue disease.

Authors:  M Tamm; A Gratwohl; A Tichelli; A P Perruchoud; A Tyndall
Journal:  Ann Rheum Dis       Date:  1996-10       Impact factor: 19.103

7.  Pre-existing autoimmune disease in patients with long-term survival after allogeneic bone marrow transplantation.

Authors:  J L Nelson; R Torrez; F M Louie; O S Choe; R Storb; K M Sullivan
Journal:  J Rheumatol Suppl       Date:  1997-05

8.  Progression of rheumatoid arthritis following bone marrow transplantation. A case report with a 13-year followup.

Authors:  R J McKendry; L Huebsch; B Leclair
Journal:  Arthritis Rheum       Date:  1996-07

9.  Autologous hematopoietic stem cell transplantation suppresses Gd-enhanced MRI activity in MS.

Authors:  G L Mancardi; R Saccardi; M Filippi; F Gualandi; A Murialdo; M Inglese; M G Marrosu; G Meucci; L Massacesi; A Lugaresi; F Pagliai; M P Sormani; F Sardanelli; A Marmont
Journal:  Neurology       Date:  2001-07-10       Impact factor: 9.910
  9 in total
  3 in total

1.  Pulmonary Arterial Hypertension-A Deadly Complication of Systemic Sclerosis.

Authors:  Edward A Pankey; Matthew Epps; Bobby D Nossaman; Albert L Hyman; Philip J Kadowitz
Journal:  J Clin Rheumatol Musculoskelet Med       Date:  2010-12-01

2.  A phase I-II trial of autologous peripheral blood stem cell transplantation in the treatment of refractory autoimmune disease.

Authors:  H Tsukamoto; K Nagafuji; T Horiuchi; T Miyamoto; K Aoki; K Takase; H Henzan; D Himeji; T Koyama; K Miyake; Y Inoue; H Nakashima; T Otsuka; Y Tanaka; K Nagasawa; M Harada
Journal:  Ann Rheum Dis       Date:  2005-08-26       Impact factor: 19.103

Review 3.  The treatment strategies of autoimmune disease may need a different approach from conventional protocol: a review.

Authors:  S Chandrashekara
Journal:  Indian J Pharmacol       Date:  2012 Nov-Dec       Impact factor: 1.200
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.